Artificial intelligence (AI) has been gaining traction in the healthcare industry as physicians and payers invest millions of dollars to streamline workflows. While the technology promises to revolutionize the way we approach healthcare, there are concerns about a lack of oversight and the potential for unintended outcomes.
At the AMA annual conference starting on June 16, AI will be one of the hot topics. One of the proposals requests is for the AMA to advocate for regulatory oversight on insurers related to claim dismissals, including advocating for a human review of claims. The use of AI in the claims process will have as large of an impact if not larger than ICD10 had more than 20 years ago on the day-to-day function and staffing for claims processing.
Another concern is AI's role in potential misinformation to patients and potentially aiding in the slander of medical professionals. While AI has been around for a while, it is not yet a failsafe tool, and there is still a long way to go before we can fully trust the technology.
Determining how to regulate AI within the healthcare industry will be a discussion point for organizations such as AMA along with federal and state governments for years to come. The test will be how to move past discussing the new challenges AI brings and implementing actual working solutions.
While AI has its advantages in healthcare, such as streamlining workflows and increasing efficiency, there are also concerns about the lack of oversight and the potential for unintended outcomes. As the industry moves forward with AI, it is crucial to keep these concerns in mind and work towards a solution that benefits both patients and medical professionals.
/Passle/5fe0c4f453548a10fc881e09/MediaLibrary/Images/2025-10-09-14-47-09-526-68e7caed09520928935393cf.png)
/Passle/5fe0c4f453548a10fc881e09/SearchServiceImages/2025-09-30-13-12-56-565-68dbd758f6347a2c4b9a81ab.jpg)
/Passle/5fe0c4f453548a10fc881e09/SearchServiceImages/2025-09-02-15-10-27-674-68b708e3a631091b7967ef21.jpg)